Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	130.02B
Revenue (ttm)	8.73B
Net Income (ttm)	2.35B
Shares Out	173.47M
EPS (ttm)	13.54
PE Ratio	55.35
Forward PE	40.91
Dividend	1.00 (0.13%)
Ex-Dividend Date	Sep 17, 2024

Volume	329,536
Average Volume	781,681
Open	785.00
Previous Close	778.95
Day's Range	740.00 - 785.00
52-Week Range	329.65 - 844.80
Beta	n/a
RSI	55.05
Earnings Date	Feb 14, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.